# Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

> **NCT06623201** · PHASE1 · RECRUITING · sponsor: **Nathalie Zeitouni** · enrollment: 20 (estimated)

## Conditions studied

- Basal Cell Carcinoma (BCC)

## Interventions

- **DRUG:** aminolevulinic acid HCL (ALA)
- **DEVICE:** BLU-U device model 4170E

## Key facts

- **NCT ID:** NCT06623201
- **Lead sponsor:** Nathalie Zeitouni
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-07
- **Primary completion:** 2026-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06623201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06623201, "Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06623201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*